|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61K 31/7125 | (2006.01) | ||
| A61K 31/04 | (2006.01) | ||
| A61K 31/166 | (2006.01) | ||
| A61K 31/52 | (2006.01) | ||
| A61K 31/7048 | (2006.01) | ||
| A61K 38/18 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 14/495 | (2006.01) |
| (11) | Number of the document | 2248895 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10009016.6 |
| Date of filing the European patent application | 2004-12-20 | |
| (97) | Date of publication of the European application | 2010-11-10 |
| (45) | Date of publication and mention of the grant of the patent | 2016-07-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 03029367 | 2003-12-19 | EP | |
| 541771 P | 2004-02-05 | US |
| (72) |
Schlingensiepen, Karl-Hermann, DE
Schlingensiepen, Reimar, DE
|
| (73) |
Autotelic LLC,
17870 Castleton Street, Suite 250, City of Industry, CA 91748,
US
|
| (54) | Combination therapy associating a TGF-beta antagonist with a chemotherapeutic agent |
| Combination therapy associating a TGF-beta antagonist with a chemotherapeutic agent |